Patient’s Self-recognition of Reduced Visual Acuity Due to Recurrence of Macular Edema and Prompt Visitation to the Hospital in Retinal Vein Occlusion
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To evaluate patients’ self-recognition of reduced visual acuity due to recurring macular edema in retinalvein occlusion. Methods: A retrospective review of medical records of patients who were diagnosed with recurring macularedema secondary to retinal vein occlusion was performed. The proportion of patients who recognized reducedvisual acuity due to the recurrence of macular edema and who visited the hospital before the scheduledfollow-up date was determined. Parameters including age, sex, diagnosis, visual acuity before recurrenceof macular edema, and extent of visual acuity reduction due to recurrence of macular edema were comparedin patients who recognized a reduction in visual acuity and those who did not. The proportion of patients whovisited the hospital promptly was also determined. Results: Forty eyes of 40 patients were included in the analysis. Sixteen and 24 patients were diagnosed withcentral retinal vein occlusion and branch retinal vein occlusion, respectively. Twenty-one patients (52.5%) recognizedreduced visual acuity due to recurring macular edema. These patients were younger (59.2 ± 7.6 vs. 64.8 ± 9.4 years, p = 0.046), had better visual acuity before recurrence of macular edema (0.52 ± 0.48 vs. 1.02± 0.46, p = 0.002), and exhibited a greater reduction in visual acuity after recurrence of macular edema (0.34± 0.24 vs. 0.14 ± 0.13, p = 0.003). Only four patients visited the hospital before the scheduled follow-up date,and all of these patients lived relatively close to the hospital. Conclusions: For prompt treatment of recurring macular edema, more intensive education about the self-estimationof visual acuity is necessary, particularly for elderly patients who have relatively poor visual acuity. Inaddition, a simple and easy way to identify the recurrence of macular edema at the local clinic should be establishedfor patients who live relatively far from the hospital.
Abstract
Purpose: To evaluate patients’ self-recognition of reduced visual acuity due to recurring macular edema in retinalvein occlusion. Methods: A retrospective review of medical records of patients who were diagnosed with recurring macularedema secondary to retinal vein occlusion was performed. The proportion of patients who recognized reducedvisual acuity due to the recurrence of macular edema and who visited the hospital before the scheduledfollow-up date was determined. Parameters including age, sex, diagnosis, visual acuity before recurrenceof macular edema, and extent of visual acuity reduction due to recurrence of macular edema were comparedin patients who recognized a reduction in visual acuity and those who did not. The proportion of patients whovisited the hospital promptly was also determined. Results: Forty eyes of 40 patients were included in the analysis. Sixteen and 24 patients were diagnosed withcentral retinal vein occlusion and branch retinal vein occlusion, respectively. Twenty-one patients (52.5%) recognizedreduced visual acuity due to recurring macular edema. These patients were younger (59.2 ± 7.6 vs. 64.8 ± 9.4 years, p = 0.046), had better visual acuity before recurrence of macular edema (0.52 ± 0.48 vs. 1.02± 0.46, p = 0.002), and exhibited a greater reduction in visual acuity after recurrence of macular edema (0.34± 0.24 vs. 0.14 ± 0.13, p = 0.003). Only four patients visited the hospital before the scheduled follow-up date,and all of these patients lived relatively close to the hospital. Conclusions: For prompt treatment of recurring macular edema, more intensive education about the self-estimationof visual acuity is necessary, particularly for elderly patients who have relatively poor visual acuity. Inaddition, a simple and easy way to identify the recurrence of macular edema at the local clinic should be establishedfor patients who live relatively far from the hospital.
참고문헌 (16)
- Rogers SL, "Natural history of branch retinal vein occlusion: an evidence-based systematic review", Ophthalmology, 117, pp.1094~1101 (2010)
- McIntosh RL, "Natural history of central retinal vein occlusion: an evidence-based systematic review", Ophthalmology, 117, pp.1113~1123 (2010)
- Campochiaro PA, "Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator", Mol Ther, 16, pp.791~799 (2008)
- Brown DM, "Ranibizumab for macular edema following central retinal vein occlusion:six-month primary end point results of a phase III study", Ophthalmology, 117, pp.1124~1133 (2010)
- Campochiaro PA, "Ranibizumab for macular edema following branch retinal vein occlusion:six-month primary end point results of a phase III study", Ophthalmology, 117, pp.1102~1112 (2010)
- 신혜영, "망막중심정맥폐쇄에 동반된 황반부종에서 라니비주맙 주입술의 단기 임상 효과", 대한안과학회지, 52(9), pp.1048~1054 (2011), 대한안과학회
- 김진영, "Comparison Between Intravitreal Bevacizumab and Triamcinolone for Macular Edema Secondary to Branch Retinal Vein Occlusion", Korean Journal of Ophthalmology, 23(4), pp.259~265 (2009), 대한안과학회
- Chen SD, "Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion", Am J Ophthalmol, 141, pp.876~883 (2006)
- Gregori NZ, "One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion", Retina, 26, pp.889~895 (2006)
- 오주연, "Early versus Late Intravitreal Triamcinolone Acetonide for Macular Edema associated with Branch Retinal Vein Occlusion", Korean Journal of Ophthalmology, 21(1), pp.18~20 (2007), 대한안과학회
- Haller JA, "Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion", Ophthalmology, 117, pp.1134~1146 (2010)
- Scott IU, "A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6", Arch Ophthalmol, 127, pp.1115~1128 (2009)
- Ip MS, "A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion:the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5", Arch Ophthalmol, 127, pp.1101~1114 (2009)
- Fine SL, "Early detection of extrafoveal neovascular membranes by daily central field evaluation", Ophthalmology, 92, pp.603~609 (1985)
- Yang CS, "Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography", Acta Ophthalmol Scand, 79, pp.266~270 (2001)
- Schaudig UH, "Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema", Ophthalmic Surg Lasers, 31, pp.182~186 (2000)